UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example AdministrableProductDefinition: Xylocain-WOP-10mgml-InjSol-SE-AJ-APD

Generated Narrative: AdministrableProductDefinition Xylocain-WOP-10mgml-InjSol-SE-AJ-APD

status: Active

formOf: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00010598,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection; indication = Intravenös regional anestesi, infiltrationsanestesi, nervblockader, epiduralanestesi. Anestesi av fingrar, tår, öron, näsa och penis eller i andra fall då adrenalin anses kontraindicerat. Vid små operativa ingrepp, då mycket kortvarig anestesi önskas. Xylocain 5 mg/ml och Xylocain 10 mg/ml är avsett för vuxna och barn över 1 år. Xylocain 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine

administrableDoseForm: Solution for injection

producedFrom: ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection; unitOfPresentation = Ampoule

routeOfAdministration

code: Intravenous use

routeOfAdministration

code: Epidural use

routeOfAdministration

code: Perineural use